Somewhat Positive Press Coverage Somewhat Unlikely to Affect Novadaq Technologies (NVDQ) Stock Price
Media stories about Novadaq Technologies (NASDAQ:NVDQ) (TSE:NDQ) have been trending somewhat positive on Sunday, according to Accern. The research group identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Novadaq Technologies earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the medical research company an impact score of 44.5035038407173 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Shares of Novadaq Technologies (NASDAQ NVDQ) traded up inf% during trading on Friday, hitting $11.75. The stock had a trading volume of 395,280 shares. The firm’s 50-day moving average is $11.68 and its 200 day moving average is $9.03. The firm’s market cap is $679.41 million. Novadaq Technologies has a 52-week low of $5.84 and a 52-week high of $12.74.
Several equities analysts have weighed in on NVDQ shares. First Analysis cut Novadaq Technologies from an “overweight” rating to an “equal weight” rating in a report on Tuesday, June 20th. Royal Bank Of Canada cut Novadaq Technologies from an “outperform” rating to a “sector perform” rating and cut their price target for the company from $12.00 to $11.75 in a report on Thursday, July 13th. Canaccord Genuity restated a “buy” rating and set a $10.00 price target on shares of Novadaq Technologies in a report on Monday, June 19th. JMP Securities restated a “market perform” rating on shares of Novadaq Technologies in a report on Thursday, July 13th. Finally, Wedbush cut Novadaq Technologies from an “outperform” rating to a “neutral” rating in a report on Monday, June 19th. One equities research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $11.86.
Novadaq Technologies Company Profile
NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.
Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.